Latest Headlines
-
QIAGEN To Enhance The Identification Of Human Remains Of Indigenous People And African Americans
7/8/2024
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a partnership with the Snow Molecular Anthropology Lab at the University of Montana in the fields of human identification and forensics.
-
ECU Health Medical Center Electrophysiology Lab Becomes First In North Carolina To Earn Accreditation By IAC
7/8/2024
ECU Health Medical Center Electrophysiology Lab is the first hospital lab in North Carolina to earn accreditation by the Intersocietal Accreditation Commission (IAC) in Cardiac Electrophysiology in the areas of Testing and Ablation, Device Implantation and Left Atrial Appendage Occlusion
-
American Medical Association Grants PLA Code To Tempus Algorithmic Test, PurIST
7/8/2024
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced that the company’s PurIST algorithmic test has received a proprietary laboratory analysis (PLA) code from the American Medical Association (AMA).
-
Anacura Acquires OHMX.bio, Adding Multi-Omics For Drug Discovery And Diagnostics To Its Services
7/4/2024
Anacura, a Ghent-based company offering medical and pharmaceutical analytical services, announces the acquisition of OHMX.bio, a Ghent University spin-off specialized in advanced -omics technology. The acquisition expands the existing anacura group activities at AnaBioTec and Labo Nuytinck towards drug discovery and diagnostics research.
-
Quest Diagnostics To Acquire Lifelabs From OMERS, Enhancing Diagnostic Services For Canadians
7/3/2024
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a definitive agreement with OMERS to acquire LifeLabs, a trusted provider of community laboratory tests for millions of Canadians, for a value of approximately CAN $1.35 billion (approximately USD $985 million), including net debt.
-
CMS Awards Tempus With Advanced Diagnostic Laboratory Test (ADLT) Status For Its xT CDx Test
7/2/2024
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced that the Centers for Medicare & Medicaid Services (CMS) has granted Advanced Diagnostic Laboratory Test (ADLT) status for Tempus’ next-generation sequencing assay, xT CDx.
-
MLM Medical Labs Poised For Growth With Facilities Expansion In Mönchengladbach
7/2/2024
MLM Medical Labs (MLM), a global leader in central and specialty laboratory services, is pleased to announce the expansion of its laboratory facilities in Mönchengladbach to support its growing operations.
-
SGS North America Announces Expansion Of Biologics Testing Capabilities
7/2/2024
SGS North America (SGS) announced today that it has added new capacity and capabilities to bolster its biologics testing services for the American biopharmaceuticals market.
-
New Lab Test To Detect Persistent HIV Strains In Africa May Aid Search For Cure
7/2/2024
A multinational team led by Weill Cornell Medicine investigators developed a test that will help measure the persistence of HIV in people affected by viral strains found predominantly in Africa—a vital tool in the search for an HIV cure that will benefit patients around the world.
-
Immunovia's New Lab Staffed And Operational After Rapid Implementation
7/2/2024
Immunovia (NASDAQ: IMMNOV) (STOCKHOLM: IMMNOV), the diagnostics company seeking to increase pancreatic cancer survival through early detection, today offers an update on its new lab in Research Triangle Park, USA.